Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Deacon's note explains impact of AIFMD for Hong Kong fund managers

Wednesday, June 05, 2013

Beverly Chandler, Opalesque London: Su Cheen Chuah of Hong Kong based law firm Deacons has written a timely note on the potential impact of Europe’s AIFMD on Hong Kong based managers.

Chuah writes: "The Alternative Investment Fund Managers Directive (AIFMD) is a European Union (EU) Directive which introduces a new regime to regulate alternative investment fund managers (AIFMs) with the aim of increasing investor protection while reducing systemic risk. It must be implemented into the national laws of EU Member States by 22 July 2013."

Fundamentally, changes introduced by the AIFMD include the requirement for the authorisation of certain AIFMs, and the imposition of certain organisational requirements and compliance obligations on AIFMs together with continuing reporting and disclosure obligations.

Beyond that, the AIFMD introduces an EU passport system for the marketing of alternative investment funds (AIFs) and it is here that an AIFM can market its funds to professional investors across the EU Member States on the back of authorisation in a single EU Member State. Chuah writes: "Although initially only applicable to EU AIFMs managing EU AIFs, from July 2015 the passport system may be extended to permit non-EU AIFMs authorised in accordance with the requirements of the AIFMD to market all AIFs to "professional investors" across the EU."

Chuah identifies five frequently asked questions Hong Kon......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for